Kolhapur Haematology And Oncology Research Centre Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.10 M
- Company Age 21 Year, 7 Months
- Last Filing with ROC 31 Mar 2013
- Open Charges ₹ 1.00 M
About Kolhapur Haematology And Oncology Research Centre
Kolhapur Haematology And Oncology Research Centre Pvt. Ltd. (KHAORCPL) is a Private Limited Indian Non-Government Company incorporated in India on 27 June 2003 and has a history of 21 years and seven months. Its registered office is in Kolhapur, Maharashtra, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2013. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹1.00 M.
Ajit Kulkarni and Vijay Hirani serve as directors at the Company.
Company Details
-
Location
Kolhapur, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U85110PN2003PTC018074
-
Company No.
018074
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
27 Jun 2003
-
Date of AGM
30 Sep 2013
-
Date of Balance Sheet
31 Mar 2013
-
Listing Status
Unlisted
-
ROC Code
Roc Pune
Industry
Who are the key members and board of directors at Kolhapur Haematology And Oncology Research Centre?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ajit Kulkarni
|
Director | 27-Jun-2003 | Current |
|
Vijay Hirani
|
Director | 27-Jun-2003 | Current |
Financial Performance of Kolhapur Haematology And Oncology Research Centre.
Enhance accessibility to Kolhapur Haematology And Oncology Research Centre's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Kolhapur Haematology And Oncology Research Centre?
Unlock access to Kolhapur Haematology And Oncology Research Centre's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹1.00 M
₹0
Charges Breakdown by Lending Institutions
- State Bank Of India : 0.10 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 31 Mar 2004 | State Bank Of India | ₹1.00 M | Open |
How Many Employees Work at Kolhapur Haematology And Oncology Research Centre?
Unlock and access historical data on people associated with Kolhapur Haematology And Oncology Research Centre, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Kolhapur Haematology And Oncology Research Centre, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kolhapur Haematology And Oncology Research Centre's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.